| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Bexgliflozin (EGT1442) |
|---|
| Description | Bexagliflozin is a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor with IC50 values of 5.6 μM and 2 nM for human SGLT1 and SGLT2, respectively. Bexagliflozin dose-dependently reduces HbA(1c) and blood glucose concentration without affecting body mass or insulin level. MW: 464.94. Purity ≥98% by HPLC |
|---|
| Size | 1 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (3R,4R,5S,6R)-2-(4-chloro-3-(4-(2-cyclopropoxyethoxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; EGT1442; THR1442 |
|---|
| Gene, Accession, CAS # | CAS: 1118567-05-7 |
|---|
| Catalog # | B1929-1 |
|---|
| Price | |
|---|
| Order / More Info | Bexgliflozin (EGT1442) from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|